Symbol="KRTX"
AssetType="Common Stock"
Name="Karuna Therapeutics Inc"
Description="Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative drugs for people living with psychiatric and neurological conditions. The company is headquartered in Boston, Massachusetts."
CIK="1771917"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="33 ARCH STREET, SUITE 3110, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="6815931000"
EBITDA="-393024000"
PERatio="None"
PEGRatio="None"
BookValue="37.71"
DividendPerShare="0"
DividendYield="0"
EPS="-9.47"
RevenuePerShareTTM="0.173"
ProfitMargin="0"
OperatingMarginTTM="-65.59"
ReturnOnAssetsTTM="-0.259"
ReturnOnEquityTTM="-0.388"
RevenueTTM="6013000"
GrossProfitTTM="10637000"
DilutedEPSTTM="-9.47"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.857"
AnalystTargetPrice="276.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="162.38"
PriceToBookRatio="5.94"
EVToRevenue="138.07"
EVToEBITDA="-25.22"
Beta="1.0"
num_52WeekHigh="276.46"
num_52WeekLow="159.73"
num_50DayMovingAverage="214.19"
num_200DayMovingAverage="205.51"
SharesOutstanding="37444000"
DividendDate="None"
ExDividendDate="None"
symbol="KRTX"
open="179.87"
high="183.99"
low="179.19"
price="182.03"
volume="254380.00"
latest_trading_day="2023-08-10"
previous_close="180.33"
change="1.70"
change_percent="0.9427%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="42"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="58"
Volume_recent_avg="422422"
Change_recent_avg="-0.23"
Delta_recent_avg="7.16"
Variance_recent_avg="3.58"
Change_ratio_recent_avg="-0.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="58"
Aroon_momentum_negative="42"
image_negative_thumbnail_id_1="1122"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_negative_thumbnail_id_2="94"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0082.jpeg"
image_neutral_thumbnail_id_1="584"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_neutral_thumbnail_id_2="580"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="965"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_positive_thumbnail_id_2="975"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
